Topic: Fen Phen

The history of the 1990s weight loss drug Fen-Phen is recalled as a cautionary tale for current GLP-1 users, noting the heart damage and lawsuits that followed its popularity. Meanwhile, the FDA has approved Ozempic for the reduction of heart disease risk, a move that ensures insurance companies must cover the expensive medication. Critics argue this is a strategy to entrench the drug in government-funded healthcare packages.

A correction is issued regarding the difference between the 1990s diet drug Fen-Phen and the synthetic opioid Fentanyl. A news report details an officer in East Liverpool, Ohio, who overdosed simply by brushing Fentanyl powder off his shirt, requiring four doses of Narcan. The drug's extreme potency leads to a discussion about its potential use as a weapon of mass destruction in public spaces.